<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508164/" ref="ordinalpos=817&amp;ncbi_uid=5657096&amp;link_uid=PMC3508164" image-link="/pmc/articles/PMC3508164/figure/F10/" class="imagepopup">Fig. 10.  From: Cripto-1 enhances the canonical Wnt/?-catenin <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> by binding to LRP5 and LRP6 co-receptors. </a></div><br /><div class="p4l_captionBody">F9 cells are more resistant to Dkk1 inhibition of the Wnt/Î²-catenin signaling pathway than F9 Cripto-1-/- cells. (A) SuperTOPFLASH assay in F9 and F9 Cripto-1-/- cells treated with rhWnt3a (100 ng/ml) alone or in combination with different concentration of rmDkk1. (B) Dkk1 mRNA expression in F9 and F9 Cripto-1-/- cells as assessed by RT-PCR.</div></div>